ESMO announces position on Data Protection Directive

ESMO (European Society for Medical Oncology) has announced their position on the Data Protection Directive.
ESMO together with EORTC (European Organization for Research and Treatment of Cancer), European, Middle Eastern & African Society for Biopreservation and Biobanking, Eurocan Platform, European Society of Surgical Oncology, European Society of Pediatric Oncology, European CanCer Organisation, European Cancer Patient Coalition, European SocieTy for Radiotherapy & Oncology, and Association of European Cancer Leagues have published a this position paper on the Data Protection Directive in Annals of Oncology.

Back to news list

Related News

  • Clinical Trials Day 2024: a Q&A on pragmatic clinical trials

  • EORTC/EMA workshop suggests an international way forward for treatment optimisation studies

  • EORTC’s Participation at the ESTRO Congress 2024

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC